OGT and pancreatic neoplasm: To determine the clinical relevance of our finding that OGT inhibits hypoxia-induced PFKFB3-S172 phosphorylation, we performed IHC to analyze OGT and PFKFB3 pSer172 levels in 73 human pancreatic tumor specimens with validation of the antibody (Fig. 6c and Fig. S6).